**Core Concept**
Opioid addiction treatment involves pharmacological interventions to manage withdrawal symptoms and cravings, with a goal of long-term recovery. Long-term maintenance therapy is crucial to prevent relapse and improve patient outcomes.

**Why the Correct Answer is Right**
Methadone is a synthetic opioid agonist used for long-term maintenance therapy in opioid addiction. It works by activating the mu-opioid receptors in the brain, providing a stable and controlled level of opioid activity, thereby reducing withdrawal symptoms and cravings. Methadone's long half-life (around 8-59 hours) allows for once-daily dosing, making it suitable for outpatient treatment programs.

**Why Each Wrong Option is Incorrect**
**Option A:** Buprenorphine is a partial opioid agonist used for opioid addiction treatment, but it's more commonly used for detoxification and short-term maintenance rather than long-term maintenance. It can be used in office-based settings, but its shorter half-life requires more frequent dosing.
**Option B:** Naltrexone is an opioid antagonist used for opioid addiction treatment, particularly for patients who have completed detoxification and are at risk of relapse. However, it's not typically used for long-term maintenance, as it can precipitate withdrawal symptoms in individuals still using opioids.
**Option C:** Clonidine is an alpha-2 adrenergic agonist used to manage opioid withdrawal symptoms, but it's not indicated for long-term maintenance therapy.

**Clinical Pearl / High-Yield Fact**
Methadone's narrow therapeutic window and potential for overdose emphasize the importance of careful dosing and monitoring in patients receiving long-term maintenance therapy.

**Correct Answer: C. Clonidine is an alpha-2 adrenergic agonist used to manage opioid withdrawal symptoms, but it's not indicated for long-term maintenance therapy.